title: Modulation of the Hedgehog signalling activity in vivo: its potential in cancer therapy
reg no: ETF6139
project type: Estonian Science Foundation research grant
status: accepted
institution: Institute of Chemical Physics and Biophysics
head of project: Illar Pata
duration: 01.01.2005 - 31.12.2008
description: Hedgehog (Hh) signalling pathway is essential in controlling patterning, growth and cell proliferation in several organ systems, in an embryo and the adult. Hh activity is therefore tightly regulated by inhibitors, such as the Hh receptor Patched (Ptch). Inappropriate activation or maintenance of Hh signalling often results in tumorigenesis (medulloblastomas and basal cell carcinomas).
This project investigates the possibility to modulate Hh signalling by downregulating the expression of activators of the Hh pathway, Gli factors, and hence restrain cancer formation. We will use mice heterozygous for Ptch that develop frequent tumors as a model system.

We take advantage of the RNA interference knockdown technology combined with Cre-lox system to identify the key targets in Hh pathway, capable of inhibiting tumor growth. As delivery system, we focus to the use of lentiviral vectors that simplify constructing transgenic mice and thus make these aims realistic. We expect that downregulation of Gli factors individually or in combination will rescue Ptch+/- phenotype. This study will provide novel insight into the role and regulation of the Hh signalling pathway. Lentiviral vectors are also potential therapeutic vehicles, and results of this study could have direct clinical applications in treatment of cancer.

project group
no name institution position  
1.Alla MaloverjanTallinn Technical UniversityResearcher 
2.Illar PataInstitute of Chemical Physics and Biophysicsassistant scientist 
3.Richard TammeInstitute of Chemical Physics and Biophysicspostdoctoral research fellow 
4.Robert TsanevKBFI/TTÜNICBP research scientist , Tallinn Technical Unive